BioMatrix Alpha Drug Eluting Coronary Stent System
Max. value paid with public resources:
Processing
Data for med. device
07IIIC5877115095
GTIN
0888889301XXXX
18/08/2022 12:14
26/06/2024 17:19
10/08/2022 14:04
Identification of the manufacturer
Biosensors Europe SA
Other
VAT number
CHE-112.284.230
CH
M
1110
J
+412 21 804 80 00
j.snoeidecastro@biosensors.com
Identification of the person placing the product on the market
Marimpex-7 Ltd
EIK
130489377
BG
SOF
Sofia
1612
бул. Цар Борис III N54
Adriana Bozhkova
02 953 25 61
02 952 58 21
office@marimpex7.bg
Identification of the wholesaler
Marimpex-7 Ltd
EIK
130489377
BG
SOF
Sofia
1612
бул. Цар Борис III N54
Adriana Bozhkova
02 953 25 61
02 952 58 21
office@marimpex7.bg
IV-Р-Т/МИ-186
11/12/2007
General medical information about the device
07 - Non-active implantable devices
Class ІІІ
Cardiovascular system
GMDN
58771
Drug eluting coronary stent, bioabsorbable-polymer
BioMatrix Alpha Drug Eluting Coronary Stent System
Description of the medical device
1
Sterility, Hospital prescription
Biolimus A9
Intended action by the manufacturer
Indicated for improving coronary luminal diameter for the
treatment of de novo lesions in native coronary arteries with a reference diameter ranging
between 2.25mm and 4.0mm. Stents with lengths 33 and 36mm are only available for
artery diameters ranging between 2.5 mm and 3.5 mm.
